How Durable Are Uterine-Sparing Treatments for Fibroids?
Many patients deliberately select uterine-sparing leiomyomata procedures to preserve their fertility and avoid major surgery. However, long-term durability data beyond five years have historically remained sparse. A recent multicenter cohort study addressed this evidence gap by tracking patients for up to ten years. Consequently, the findings provide vital guidance for clinicians counseling women with symptomatic fibroids.
Long-Term Durability of Uterine-Sparing Leiomyomata Procedures
The study analyzed 817 women who underwent uterine-sparing interventions. Specifically, baseline treatments included myomectomy, endometrial ablation, radiofrequency ablation, and uterine artery embolization. The median participant age was 39.7 years at baseline and 46.8 years at recontact. Remarkably, 79.1% of participants remained free from any subsequent uterine procedures at five years. Furthermore, 64.1% required no additional interventions at ten years. Therefore, most patients achieve lasting symptom control without subsequent surgery.
Retreatment Patterns and Subsequent Interventions
Overall, 28.7% of participants eventually underwent a secondary intervention during follow-up. Among retreated women, hysterectomy represented the most frequent procedure at 46.1%. In addition, myomectomy accounted for 27.9% of reinterventions, while uterine artery embolization represented 12.7%. Importantly, retreatment risk varied significantly across the different baseline procedure types. When compared with myomectomy, radiofrequency ablation carried a significantly higher retreatment hazard. Conversely, patients who initially received myomectomy were the least likely to undergo subsequent hysterectomy. In contrast, women receiving endometrial ablation had the highest subsequent hysterectomy rate at 22.2%.
Clinical Implications for Gynecological Practice
These long-term findings offer reassuring evidence for patient counseling. Specifically, gynecologists can reassure patients that uterine preservation remains successful for the majority over ten years. Nonetheless, clinicians must tailor procedure selection to each patient's specific anatomy and reproductive desires. Because radiofrequency ablation showed higher reintervention rates, physicians should discuss retreatment expectations proactively. Ultimately, clear communication ensures shared decision-making aligned with personal reproductive goals.
Frequently Asked Questions
Q1: What percentage of patients avoid retreatment after uterine-sparing procedures?
Nearly 80% of patients avoid additional uterine procedures within five years. Furthermore, approximately 64% remain completely retreatment-free at ten years.
Q2: Which uterine-sparing procedure has the lowest rate of subsequent hysterectomy?
Patients undergoing myomectomy show the lowest long-term risk of hysterectomy at approximately 11%. Conversely, women undergoing endometrial ablation face the highest hysterectomy risk at 22.2%.
Q3: Why did radiofrequency ablation show a higher retreatment risk?
Radiofrequency ablation yielded a 1.61-fold higher hazard of retreatment compared to surgical myomectomy. Therefore, residual or newly developing fibroid tissue may require subsequent targeted therapy.
References
- Graham McNeil K et al. Patient Report of Subsequent Uterine-Sparing Leiomyomata Procedures up to 10 Years. Obstet Gynecol. 2026 Nov 10. doi: 10.1097/AOG.0000000000006459. PMID: 43008239.
- Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043.
- Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol. 2010;202(6):514-521.
